Inogen Company Profile (NASDAQ:INGN)

About Inogen

Inogen logoInogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: INGN
  • CUSIP:
Key Metrics:
  • Previous Close: $69.22
  • 50 Day Moving Average: $66.11
  • 200 Day Moving Average: $61.96
  • 52-Week Range: $32.49 - $69.94
  • Trailing P/E Ratio: 97.49
  • Foreward P/E Ratio: 88.74
  • P/E Growth: 3.70
  • Market Cap: $1.40B
  • Outstanding Shares: 20,260,000
  • Beta: 1.07
  • Net Margins: 7.70%
  • Return on Equity: 9.59%
  • Return on Assets: 7.81%
  • Current Ratio: 5.23%
  • Quick Ratio: 4.68%
Additional Links:
Companies Related to Inogen:

Analyst Ratings

Consensus Ratings for Inogen (NASDAQ:INGN) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $59.60 (13.90% downside)

Analysts' Ratings History for Inogen (NASDAQ:INGN)
DateFirmActionRatingPrice TargetDetails
1/19/2017Needham & Company LLCBoost Price TargetStrong-Buy$66.00 -> $78.00View Rating Details
8/5/2016J P Morgan Chase & CoBoost Price TargetOverweight$60.00 -> $62.00View Rating Details
8/5/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
6/8/2016Leerink SwannReiterated RatingOutperform$60.00View Rating Details
3/24/2016Piper Jaffray CompaniesInitiated CoverageNeutral$46.00View Rating Details
(Data available from 2/25/2015 forward)


Earnings History for Inogen (NASDAQ:INGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2017Q416$0.10$46.19 millionN/AView Earnings Details
11/3/2016Q316$0.13$0.16$47.89 million$54.42 millionViewN/AView Earnings Details
8/4/2016Q216$0.20$0.25$52.44 million$54.57 millionViewN/AView Earnings Details
5/9/2016Q116$0.12$0.11$41.75 million$43.00 millionViewN/AView Earnings Details
3/14/2016Q415$0.07$0.19$29.10 million$40.40 millionViewN/AView Earnings Details
11/10/2015Q315$0.13$0.13$36.99 million$40.80 millionViewListenView Earnings Details
8/11/2015Q215$0.14$0.17$36.88 million$44.00 millionViewListenView Earnings Details
5/12/2015Q1$0.07$0.08$29.98 million$33.70 millionViewListenView Earnings Details
4/27/2015Q115$0.02$0.06$19.80 million$29.10 millionViewN/AView Earnings Details
11/11/2014$0.06$0.11$28.00 million$29.40 millionViewN/AView Earnings Details
8/12/2014Q214$0.07$0.11$23.93 million$30.40 millionViewN/AView Earnings Details
5/13/2014Q114$0.04$0.05$20.70 million$23.60 millionViewN/AView Earnings Details
3/27/2014Q4 13$0.02$0.89$18.71 million$19.76 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Inogen (NASDAQ:INGN)
Current Year EPS Consensus Estimate: $0.62 EPS
Next Year EPS Consensus Estimate: $0.78 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.10$0.13$0.12
Q2 20162$0.18$0.18$0.18
Q3 20162$0.11$0.15$0.13
Q4 20162$0.05$0.12$0.09
Q1 20172$0.07$0.09$0.08
Q2 20172$0.27$0.29$0.28
Q3 20172$0.17$0.19$0.18
Q4 20172$0.13$0.18$0.16
Q1 20181$0.12$0.12$0.12
Q2 20181$0.39$0.39$0.39
Q3 20181$0.23$0.23$0.23
(Data provided by Zacks Investment Research)


Dividend History for Inogen (NASDAQ:INGN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Inogen (NASDAQ:INGN)
Insider Ownership Percentage: 5.18%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/17/2017Matt ScribnerEVPSell2,500$63.91$159,775.00View SEC Filing  
1/17/2017Raymond HuggenbergerCEOSell5,680$63.96$363,292.80View SEC Filing  
1/10/2017Brenton TaylorEVPSell5,105$65.31$333,407.55View SEC Filing  
1/3/2017Brenton TaylorEVPSell31,823$65.69$2,090,452.87View SEC Filing  
12/15/2016Raymond HuggenbergerCEOSell8,000$65.59$524,720.00View SEC Filing  
12/14/2016Matt ScribnerEVPSell2,500$65.13$162,825.00View SEC Filing  
12/1/2016Scott WilkinsonInsiderSell26,706$61.64$1,646,157.84View SEC Filing  
11/14/2016Matt ScribnerEVPSell2,500$63.80$159,500.00View SEC Filing  
10/17/2016Raymond HuggenbergerCEOSell7,089$56.24$398,685.36View SEC Filing  
10/12/2016Matt ScribnerEVPSell4,551$59.45$270,556.95View SEC Filing  
9/19/2016Matt ScribnerEVPSell4,551$60.18$273,879.18View SEC Filing  
9/16/2016Byron MyersVPSell6,200$60.04$372,248.00View SEC Filing  
9/9/2016Byron MyersVPSell3,800$60.07$228,266.00View SEC Filing  
8/18/2016Matt ScribnerEVPSell2,320$56.39$130,824.80View SEC Filing  
8/15/2016Raymond HuggenbergerCEOSell20,747$57.48$1,192,537.56View SEC Filing  
8/9/2016Byron MyersVPSell13,000$55.00$715,000.00View SEC Filing  
7/18/2016Matt ScribnerEVPSell4,102$50.46$206,986.92View SEC Filing  
7/18/2016Raymond HuggenbergerCEOSell20,747$50.41$1,045,856.27View SEC Filing  
6/16/2016Matt ScribnerEVPSell4,102$47.66$195,501.32View SEC Filing  
6/16/2016Raymond HuggenbergerCEOSell20,747$47.86$992,951.42View SEC Filing  
5/16/2016Matt ScribnerEVPSell4,102$43.82$179,749.64View SEC Filing  
5/16/2016Raymond HuggenbergerCEOSell20,746$44.18$916,558.28View SEC Filing  
4/15/2016Matt ScribnerEVPSell4,102$48.62$199,439.24View SEC Filing  
4/15/2016Raymond HuggenbergerCEOSell29,635$48.59$1,439,964.65View SEC Filing  
4/13/2016Brenton TaylorEVPSell6,500$48.00$312,000.00View SEC Filing  
4/6/2016Alison BauerleinCFOSell9,278$46.18$428,458.04View SEC Filing  
3/31/2016Alison BauerleinCFOSell4,360$44.33$193,278.80View SEC Filing  
2/16/2016Matt ScribnerEVPSell4,102$30.26$124,126.52View SEC Filing  
1/14/2016Matt ScribnerEVPSell4,102$34.73$142,462.46View SEC Filing  
12/14/2015Matt ScribnerEVPSell4,102$40.40$165,720.80View SEC Filing  
11/12/2015Matt ScribnerEVPSell4,102$44.52$182,621.04View SEC Filing  
10/26/2015Brenton TaylorEVPSell5,000$41.38$206,900.00View SEC Filing  
10/21/2015Raymond HuggenbergerCEOSell57,418$43.06$2,472,419.08View SEC Filing  
10/12/2015Matt ScribnerEVPSell4,102$44.06$180,734.12View SEC Filing  
10/1/2015Alison BauerleinCFOSell10,185$47.94$488,268.90View SEC Filing  
9/25/2015Brenton TaylorEVPSell3,333$53.48$178,248.84View SEC Filing  
9/16/2015Byron MyersVPSell1,700$55.00$93,500.00View SEC Filing  
9/15/2015Raymond HuggenbergerCEOSell57,416$53.58$3,076,349.28View SEC Filing  
9/14/2015Byron MyersVPSell7,950$55.23$439,078.50View SEC Filing  
9/10/2015Matt ScribnerEVPSell4,102$53.30$218,636.60View SEC Filing  
9/1/2015Alison BauerleinCFOSell6,500$48.21$313,365.00View SEC Filing  
8/26/2015Scott WilkinsonEVPSell6,666$45.42$302,769.72View SEC Filing  
8/25/2015Brenton TaylorEVPSell3,333$46.84$156,117.72View SEC Filing  
8/25/2015Ray Benjamin M. AndersonDirectorSell5,658$46.36$262,304.88View SEC Filing  
5/28/2015Timothy PetersenDirectorSell337,081$37.44$12,620,312.64View SEC Filing  
5/26/2015Timothy PetersenDirectorSell54,258$37.05$2,010,258.90View SEC Filing  
5/22/2015Timothy PetersenDirectorSell86,889$37.09$3,222,713.01View SEC Filing  
5/21/2015Timothy PetersenDirectorSell134,300$37.81$5,077,883.00View SEC Filing  
5/19/2015Timothy PetersenDirectorSell115,700$37.25$4,309,825.00View SEC Filing  
5/18/2015Timothy PetersenDirectorSell58,987$37.35$2,203,164.45View SEC Filing  
3/5/2015Matt ScribnerEVPSell4,102$33.69$138,196.38View SEC Filing  
2/25/2015Brenton TaylorEVPSell15,687$33.87$531,318.69View SEC Filing  
2/23/2015Alison BauerleinCFOSell15,687$33.10$519,239.70View SEC Filing  
2/19/2015Raymond HuggenbergerCEOSell25,722$33.95$873,261.90View SEC Filing  
2/13/2015Scott WilkinsonEVPSell18,333$32.87$602,605.71View SEC Filing  
2/5/2015Matt ScribnerEVPSell4,102$30.66$125,767.32View SEC Filing  
2/3/2015Timothy PetersenDirectorSell17,000$30.25$514,250.00View SEC Filing  
2/2/2015Timothy PetersenDirectorSell99,000$30.88$3,057,120.00View SEC Filing  
1/29/2015Timothy PetersenDirectorSell601,000$31.95$19,201,950.00View SEC Filing  
1/26/2015Brenton TaylorEVPSell15,687$31.53$494,611.11View SEC Filing  
1/23/2015Alison BauerleinCFOSell15,687$31.53$494,611.11View SEC Filing  
1/20/2015Raymond HuggenbergerCEOSell25,722$31.63$813,586.86View SEC Filing  
1/5/2015Matt ScribnerEVPSell4,102$31.14$127,736.28View SEC Filing  
1/5/2015Versant Ventures Ii LlcMajor ShareholderSell7,946$30.98$246,167.08View SEC Filing  
12/30/2014Scott WilkinsonEVPSell962$30.50$29,341.00View SEC Filing  
12/29/2014Scott WilkinsonEVPSell15,735$30.52$480,232.20View SEC Filing  
12/24/2014Byron MyersVPSell7,514$30.07$225,945.98View SEC Filing  
12/23/2014Alison BauerleinCFOSell15,687$29.85$468,256.95View SEC Filing  
12/23/2014Byron MyersVPSell3,018$30.04$90,660.72View SEC Filing  
12/23/2014Versant Ventures Ii LlcMajor ShareholderSell9,785$29.74$291,005.90View SEC Filing  
12/22/2014Byron MyersVPSell11,801$30.06$354,738.06View SEC Filing  
12/22/2014Scott WilkinsonEVPSell1,033$30.31$31,310.23View SEC Filing  
12/19/2014Raymond HuggenbergerCEOSell25,722$28.98$745,423.56View SEC Filing  
12/11/2014Scott WilkinsonEVPSell14,700$25.25$371,175.00View SEC Filing  
12/3/2014Matt ScribnerEVPSell4,102$24.09$98,817.18View SEC Filing  
11/25/2014Brenton TaylorEVPSell15,687$24.71$387,625.77View SEC Filing  
11/21/2014Alison BauerleinCFOSell15,687$24.49$384,174.63View SEC Filing  
11/19/2014Raymond HuggenbergerCEOSell25,722$24.25$623,758.50View SEC Filing  
11/19/2014Versant Ventures Ii LlcMajor ShareholderSell28,225$24.77$699,133.25View SEC Filing  
11/18/2014Scott WilkinsonEVPSell2,233$25.21$56,293.93View SEC Filing  
11/18/2014Versant Ventures Ii LlcMajor ShareholderSell11,848$24.83$294,185.84View SEC Filing  
11/17/2014Versant Ventures Ii LlcMajor ShareholderSell5,343$24.89$132,987.27View SEC Filing  
11/14/2014Heather D RiderDirectorBuy3,000$25.00$75,000.00View SEC Filing  
11/14/2014Scott WilkinsonEVPSell1,100$25.15$27,665.00View SEC Filing  
11/14/2014Versant Ventures Ii LlcMajor ShareholderSell9,433$25.13$237,051.29View SEC Filing  
11/10/2014Versant Ventures Ii LlcMajor ShareholderSell2,992$24.42$73,064.64View SEC Filing  
11/7/2014Versant Ventures Ii LlcMajor ShareholderSell7,388$24.30$179,528.40View SEC Filing  
11/4/2014A/S NovoMajor ShareholderSell2,000,000$21.50$43,000,000.00View SEC Filing  
11/4/2014Raymond HuggenbergerCEOSell165,891$20.21$3,352,657.11View SEC Filing  
11/4/2014Timothy PetersenDirectorSell250,000$21.50$5,375,000.00View SEC Filing  
11/3/2014Matt ScribnerEVPSell4,102$24.08$98,776.16View SEC Filing  
10/29/2014Scott WilkinsonEVPSell18,333$22.41$410,842.53View SEC Filing  
10/27/2014Brenton TaylorEVPSell15,687$21.67$339,937.29View SEC Filing  
10/24/2014Versant Ventures Ii LlcMajor ShareholderSell4,647$20.76$96,471.72View SEC Filing  
10/23/2014Alison BauerleinCFOSell15,687$20.50$321,583.50View SEC Filing  
10/9/2014Versant Ventures Ii LlcMajor ShareholderSell1,900$20.83$39,577.00View SEC Filing  
10/8/2014Versant Ventures Ii LlcMajor ShareholderSell6,907$21.03$145,254.21View SEC Filing  
10/7/2014Timothy PetersenDirectorSell31,600$21.55$680,980.00View SEC Filing  
10/6/2014Timothy PetersenDirectorSell17,475$21.56$376,761.00View SEC Filing  
10/3/2014Timothy PetersenDirectorSell31,658$21.52$681,280.16View SEC Filing  
10/3/2014Ventures Lp Arboretum IIMajor ShareholderSell98,400$20.97$2,063,448.00View SEC Filing  
10/2/2014Timothy PetersenDirectorSell24,597$20.91$514,323.27View SEC Filing  
10/1/2014Matt ScribnerEVPSell8,204$20.25$166,131.00View SEC Filing  
10/1/2014Timothy PetersenDirectorSell42,145$20.61$868,608.45View SEC Filing  
9/30/2014Timothy PetersenDirectorSell84,500$20.23$1,709,435.00View SEC Filing  
9/24/2014Ventures Lp Arboretum IIMajor ShareholderSell83,500$20.34$1,698,390.00View SEC Filing  
9/23/2014Alison BauerleinCFOSell15,687$20.01$313,896.87View SEC Filing  
9/22/2014Raymond HuggenbergerCEOSell25,722$20.25$520,870.50View SEC Filing  
9/22/2014Timothy PetersenDirectorSell46,865$21.05$986,508.25View SEC Filing  
9/17/2014Timothy PetersenDirectorSell39,135$21.72$850,012.20View SEC Filing  
9/17/2014Ventures Lp Arboretum IIMajor ShareholderSell55,135$21.61$1,191,467.35View SEC Filing  
9/16/2014Timothy PetersenDirectorSell6,500$21.16$137,540.00View SEC Filing  
9/15/2014Byron MyersVPSell22,333$21.33$476,362.89View SEC Filing  
9/15/2014Scott WilkinsonEVPSell18,333$21.42$392,692.86View SEC Filing  
9/15/2014Timothy PetersenDirectorSell9,500$21.45$203,775.00View SEC Filing  
9/9/2014Versant Ventures Ii LlcMajor ShareholderSell7,388$23.25$171,771.00View SEC Filing  
3/7/2014Charles E LarsenDirectorSell26,201$14.88$389,870.88View SEC Filing  
2/20/2014A/S NovoInsiderSell617,000$14.88$9,180,960.00View SEC Filing  
2/20/2014Loren L McfarlandDirectorBuy3,125$16.00$50,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Inogen (NASDAQ:INGN)
News IconWhat is the Sell-side Saying About Inogen, Inc (NASDAQ:INGN)? - Aiken Advocate (NASDAQ:INGN) - February 24 at 10:13 AM
News IconAre Analysts Optimistic About Where Inogen, Inc (NASDAQ:INGN) is Heading? - Winfield Review (NASDAQ:INGN) - February 24 at 10:13 AM
News IconAnalysts Peer Into Their Crystal Balls For Inogen, Inc (NASDAQ:INGN): Where Is It headed? - Winfield Review (NASDAQ:INGN) - February 22 at 12:39 PM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Inogen, Inc (NASDAQ:INGN) Stock - Aiken Advocate (NASDAQ:INGN) - February 15 at 9:05 PM
News IconWatching the Numbers on These Shares: Inogen, Inc. (NASDAQ:INGN) - Midway Monitor (NASDAQ:INGN) - February 15 at 5:20 AM
News IconStock Floating Above Moving Averages: Inogen, Inc. (NASDAQ:INGN) - Winfield Review (NASDAQ:INGN) - February 15 at 5:20 AM
News IconFollowing the Numbers for Inogen Inc (INGN) - Benton Bulletin (NASDAQ:INGN) - February 9 at 6:50 PM logoInogen to Announce Fourth Quarter and Full Year 2016 Results on Tuesday, February 28, 2017 (NASDAQ:INGN) - February 6 at 6:01 PM logoInogen : to Participate in Upcoming Investor Conferences (NASDAQ:INGN) - February 3 at 6:29 PM logoInogen to Participate in Upcoming Investor Conferences (NASDAQ:INGN) - February 2 at 6:37 PM
News IconStock Survey: Viewing Levels for Inogen, Inc. (NASDAQ:INGN) - The Tribune (NASDAQ:INGN) - January 29 at 6:11 PM
News IconWatching the ATR on Shares of Inogen Inc (INGN) - Market Point (NASDAQ:INGN) - January 29 at 6:11 PM
News IconWith Markets Booming Higher, Is This Stock Fairly Valued: Inogen, Inc. (NASDAQ:INGN) - Aiken Advocate (NASDAQ:INGN) - January 26 at 7:37 PM
News IconConsensus Take: Inogen, Inc (NASDAQ:INGN) Earnings & Ratings Watch - Aiken Advocate (NASDAQ:INGN) - January 26 at 5:23 AM
News IconStock to Watch: Inogen Inc (INGN) - Springdale Times (NASDAQ:INGN) - January 26 at 5:23 AM
News IconEarnings in Full Force, Analysts Take Aim at Inogen, Inc (NASDAQ:INGN) - Wall Street Beacon (NASDAQ:INGN) - January 26 at 5:23 AM
News IconF-Score in Review on Shares of Inogen, Inc. (NASDAQ:INGN) - The Tribune (NASDAQ:INGN) - January 24 at 6:40 PM logoCommit To Buy Inogen At $55, Earn 14.9% Annualized Using Options - Nasdaq (NASDAQ:INGN) - January 20 at 3:30 PM logoInogen (INGN) G4 Product Cycle Should Improve In 2017 - Needham - (NASDAQ:INGN) - January 20 at 12:43 AM logoInogen (INGN) G4 Product Cycle Should Improve In 2017 - Needham (NASDAQ:INGN) - January 19 at 7:42 PM logoInogen, Inc. – Value Analysis (NASDAQ:INGN) : January 19, 2017 (NASDAQ:INGN) - January 19 at 7:42 PM logoInogen, Inc. breached its 50 day moving average in a Bearish Manner : INGN-US : January 18, 2017 (NASDAQ:INGN) - January 18 at 6:25 PM logoInogen, Inc (NASDAQ:INGN) Mean Rating At $1.67 - (NASDAQ:INGN) - January 16 at 5:55 PM logoInogen (INGN) Presents At 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:INGN) - January 12 at 6:23 PM logoInogen Provides Impact from 21st Century Cures Act (NASDAQ:INGN) - January 9 at 6:41 PM logo6:00 am Inogen announces the estimated impact of the 21st Century Cures Act to its 2016 financial results; estimates an increase in rental revs of up to $2.0 mln in 4Q16 based on preliminary (NASDAQ:INGN) - January 9 at 6:41 PM logoINOGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Sta (NASDAQ:INGN) - January 9 at 6:41 PM
News IconInogen, Inc. INGN Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:INGN) - January 5 at 7:12 PM logoETFs with exposure to Inogen, Inc. : December 21, 2016 (NASDAQ:INGN) - December 21 at 6:47 PM
News IconStock Watch: FCF Score Check on Inogen, Inc. (NASDAQ:INGN) - Marion Business Daily (NASDAQ:INGN) - December 14 at 4:24 AM
News IconInogen Inc Valuation – Initial Coverage $INGN (NASDAQ:INGN) - December 13 at 6:23 PM logoResearch Analysts Set Inogen, Inc (NASDAQ:INGN) Price Target at $66.6 (NASDAQ:INGN) - December 12 at 6:02 PM logoInogen Inc (INGN): Why is Smart Money Unloading This Stock? (NASDAQ:INGN) - December 12 at 6:02 PM logoResearch Analysts Set Inogen, Inc (NASDAQ:INGN) Price Target at $66.6 - (NASDAQ:INGN) - December 11 at 5:17 PM
News IconAverage True Range in the Spotlight: Inogen Inc (INGN) - StockTalk Daily (NASDAQ:INGN) - December 11 at 5:17 PM
News IconChecking the Levels on Shares of Inogen, Inc. (NASDAQ:INGN) - The Business Journal (NASDAQ:INGN) - December 11 at 10:25 AM logoInogen Inc (INGN) Showing Resistance Near $66.84 (NASDAQ:INGN) - December 10 at 11:56 AM
News IconNoteworthy Thursday Option Activity: INGN, RDUS, WBMD (NASDAQ:INGN) - December 8 at 6:34 PM logoInogen names new CEO; reaffirms 2016 & 2017 guidance (NASDAQ:INGN) - December 8 at 10:35 AM logoInogen Names Scott Wilkinson President, CEO, Effective March 1; Backs FY Outlook (NASDAQ:INGN) - December 6 at 3:43 PM logoINOGEN INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stateme (NASDAQ:INGN) - December 6 at 3:43 PM logoBRIEF-Inogen appointed Scott Wilkinson CEO on Dec. 1 (NASDAQ:INGN) - December 6 at 6:37 AM
News IconLooking at the Numbers for Inogen, Inc. (NASDAQ:INGN) - Marion Business Daily (NASDAQ:INGN) - December 6 at 5:58 AM logoInogen Announces Management Transitions and Expanded Board of Directors (NASDAQ:INGN) - December 6 at 5:58 AM logo4:16 am Inogen announces Scott Wilkinson to succeed Raymond Huggenberger as CEO effective Mar 1, 2017; reiterates 2016 and 2017 guidance (NASDAQ:INGN) - December 6 at 5:58 AM logoMean Rating Of Inogen, Inc (NASDAQ:INGN) At $1.67 - (NASDAQ:INGN) - December 5 at 3:21 PM logoETFs with exposure to Inogen, Inc. : December 5, 2016 (NASDAQ:INGN) - December 5 at 3:21 PM logoInogen, Inc (NASDAQ:INGN) Rating At 1.67 - Investor Newswire (NASDAQ:INGN) - December 4 at 10:22 AM
News IconInvestor Hub: Checking on the Numbers for Inogen, Inc. (NASDAQ:INGN) - Marion Business Daily (NASDAQ:INGN) - December 1 at 5:54 PM
News IconPrice Index Watch on Shares of Inogen, Inc. (NASDAQ:INGN) - Marion Business Daily (NASDAQ:INGN) - November 30 at 9:36 AM


What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

Where is Inogen's stock going? Where will Inogen's stock price be in 2017?

5 brokers have issued twelve-month price targets for Inogen's shares. Their predictions range from $46.00 to $78.00. On average, they expect Inogen's stock price to reach $59.60 in the next year.

When will Inogen announce their earnings?

Inogen is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

Who owns Inogen stock?

Inogen's stock is owned by a number of of institutional and retail investors. Top institutional investors include Novo A S (17.52%), Brown Capital Management LLC (7.00%), Dimensional Fund Advisors LP (2.46%), Loomis Sayles & Co. L P (1.89%), Cortina Asset Management LLC (1.87%) and State Street Corp (1.82%). Company insiders that own Inogen stock include Alison Bauerlein, Brenton Taylor, Byron Myers, Matt Scribner, Ray Benjamin M Anderson, Raymond Huggenberger, Scott Wilkinson and Timothy Petersen.

Who sold Inogen stock? Who is selling Inogen stock?

Inogen's stock was sold by a variety of institutional investors in the last quarter, including Fred Alger Management Inc., Allianz Asset Management AG, Two Sigma Investments LP, Royce & Associates LP, Thornburg Investment Management Inc., Thrivent Financial for Lutherans, Renaissance Technologies LLC and Cortina Asset Management LLC. Company insiders that have sold Inogen stock in the last year include Alison Bauerlein, Brenton Taylor, Byron Myers, Matt Scribner, Raymond Huggenberger and Scott Wilkinson.

Who bought Inogen stock? Who is buying Inogen stock?

Inogen's stock was bought by a variety of institutional investors in the last quarter, including Brown Capital Management LLC, Marshall Wace LLP, Russell Investments Group Ltd., Highland Capital Management LP, Axiom International Investors LLC DE, State Street Corp, Osterweis Capital Management Inc. and Folger Hill Asset Management LP.

How do I buy Inogen stock?

Shares of Inogen can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Inogen stock cost?

One share of Inogen stock can currently be purchased for approximately $69.22.

Inogen (NASDAQ:INGN) Chart for Saturday, February, 25, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Inogen (NASDAQ:INGN)

Earnings History Chart

Earnings by Quarter for Inogen (NASDAQ:INGN)

Dividend History Chart

Dividend Payments by Quarter for Inogen (NASDAQ:INGN)

Last Updated on 2/25/2017 by Staff